1Plutzky J (2004) Inflammation in atherosclerosis and diabetes mellitus. Rev Endocr Metab Disord 5, 255–259.
2Hu FB, Meigs JB, Li TY, Rifai N & Manson JE (2004) Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53, 693–700.
3Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR & Heiss G (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52, 1799–1805.
4Polonsky KS (2006) Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med 354, 2596–2598.
5Qi Q, Yu Z, Ye X, et al. (2007) Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 92, 4827–4834.
6Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V & George D (2007) Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 92, 1971–1974.
7Bhathena SJ & Velasquez MT (2002) Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76, 1191–1201.
8Bloedon LT & Szapary PO (2004) Flaxseed and cardiovascular risk. Nutr Rev 62, 18–27.
9Si H & Liu D (2007) Phytochemical genistein in the regulation of vascular function: new insights. Curr Med Chem 14, 2581–2589.
10Kurzer MS & Xu X (1997) Dietary phytoestrogens. Annu Rev Nutr 17, 353–381.
11Hallund J, Tetens I, Bugel S, Tholstrup T & Bruun JM (2008) The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis 18, 497–502.
12Hall WL, Vafeiadou K, Hallund J, et al. (2005) Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82, 1260–1268.
13Nikander E, Metsa-Heikkila M, Tiitinen A & Ylikorkala O (2003) Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 88, 5180–5185.
14D'Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A & Squadrito F (2005) The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand 84, 474–477.
15Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR & Beerman KA (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83, 1118–1125.
16Hanson LN, Engelman HM, Alekel DL, Schalinske KL, Kohut ML & Reddy MB (2006) Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr 84, 774–780.
17Pan A, Sun J, Chen Y, et al. (2007) Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS ONE 2, e1148.
18Teede HJ, Dalais FS & McGrath BP (2004) Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am J Clin Nutr 79, 396–401.
19Faintuch J, Horie LM, Barbeiro HV, Barbeiro DF, Soriano FG, Ishida RK & Cecconello I (2007) Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid. Obes Surg 17, 341–347.
20Azadbakht L, Atabak S & Esmaillzadeh A (2008) Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 31, 648–654.
21Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB & Willett WC (2007) Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 30, 967–973.
22Dodin S, Cunnane SC, Masse B, et al. (2008) Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 24, 23–30.
23Bloedon LT, Balikai S, Chittams J, et al. (2008) Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27, 65–74.
24Lu LJ & Anderson KE (1998) Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr 68, Suppl. 6, S1500–S1504.
25Jenkins DJ, Kendall CW, Connelly PW, Jackson CJT, Parker T, Faulkner D & Vidgen E (2002) Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 51, 919–924.
26Calabro P, Willerson JT & Yeh ET (1997) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 21, (108), 1930–1932.
27Ng TW, Watts GF, Barrett PH, Rye KA & Chan DC (2007) Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care 30, 2945–2950.